Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Drug Importation Task Force: FDA Reps Are Crawford, Sachdev

Executive Summary

The HHS Task Force on Drug Importation includes at least three representatives from outside FDA who are likely to be primarily concerned with protecting the pharmaceutical supply chain

You may also be interested in...



Rx Importation Unsustainable Because Of Supply/Demand Imbalance – HDMA

Increased demand for a small amount of Canadian pharmaceuticals would make a legalized importation system unsustainable, drug distributors told the HHS importation task force

PhRMA Braces For Import Fight; Trade Treaties May Help, Sen. Breaux Says

Every U.S. trade agreement should be examined for its potential impact on prescription drug pricing, Sen. John Breaux (D-La.) said during the Pharmaceutical Research & Manufacturers of America's annual meeting in Palm Beach, Fla. April 3

Rx Importation Unsustainable Because Of Supply/Demand Imbalance – HDMA

Increased demand for a small amount of Canadian pharmaceuticals would make a legalized importation system unsustainable, drug distributors told the HHS importation task force

Related Content

UsernamePublicRestriction

Register

MT101489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel